secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0001193125-24-007674
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Inovio shareholders approve reverse stock split at ratios from 1:10 to 1:50
---------------------------------------------------------------------------

- 146,265,973 shares (53.6%) present; reverse split approved with 96,534,629 For vs 48,857,255 Against.
- Board authorized to implement split at any time within one year of Jan 12, 2024 special meeting.
- Split ratio range 1-for-10 to 1-for-50, exact ratio to be determined by Board later.
- Adjournment proposal also approved (106,842,257 For) to allow additional solicitation if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524007674/0001193125-24-007674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524007674/d722280d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-007674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer